Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN 2)

Publié le 1 Janvier 2004
Mis à jour le 10 Septembre 2019

Serological surveillance is an important resource to evaluate vaccine programmes, especially for diseases such as rubella, where a suboptimal programme can lead to an increase in morbidity. A coordinated vaccine policy in Europe is needed and the aim of the European Sero-Epidemiology Network (ESEN2) is to standardise serological surveillance in 22 countries for eight diseases, including rubella. (R.A.)

Auteur : Nardone A, Miller E
Eurosurveillance. European communicable disease quarterly, 2004, vol. 9, n°. 2, p. 5-7